Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Phase II Pilot Study of 3 Weekly Cabazitaxel Versus Weekly Paclitaxel Chemotherapy in the First Line Treatment of HER2 Negative Breast Cancer

NCT03048942 is registered in ClinicalTrials.gov with University Hospitals Bristol and Weston NHS Foundation Trust as lead sponsor.

NCT NCT03048942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03048942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Phase II Pilot Study of 3 Weekly Cabazitaxel Versus Weekly Paclitaxel Chemotherapy in the First Line Treatment of HER2 Negative Breast Cancer
Lead sponsor
University Hospitals Bristol and Weston NHS Foundation Trust
Phase
Phase 2
Overall status
Completed
Start date
December 18, 2014
Completion date
March 19, 2025
Enrollment
158 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

her2 negative metastatic breast cancer